The ISCHEMIA biorepository is a collection of genetic and biomarker samples from randomized participants in the ISCHEMIA and ISCHEMIA-CKD trials. The biorepository will prove an invaluable resource to advance understanding of diagnosis, pathogenesis and outcomes of patients with stable ischemic heart disease. We anticipate this repository will provide a wealth of opportunities for future investigations.
Currently, there are samples from approximately 700-1,000 participants in the biorepository across 6 different sample types.
- DNA (whole blood and/or saliva)
- Whole blood RNA
- Buffy coat
- Red blood cells
Investigators interested in learning more about the ISCHEMIA biorepository should contact us at email@example.com.
- Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials. American Heart Journal. December 2023 Link